BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

772

500096

DABUR

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

DABUR INDIA LTD performance

Today’s low

Today’s high

₹ 482.35 ₹ 490.45
₹ 487.75

52 week low

52 week high

₹ 433.30 ₹ 672.00
₹ 487.75

Open Price

₹ 483.60

Prev. Close

₹ 483.65

Volume (Shares)

2195362.00

Total traded value

₹ 10707.87

Upper Circuit

₹ 532.00

Lower Circuit

₹ 435.30

info

DABUR INDIA LTD Share Price Update

As of the latest trading session, DABUR INDIA LTD share price is currently at ₹ 487.75, which is up by ₹ 4.10 from its previous closing. Today, the stock has fluctuated between ₹ 482.35 and ₹ 490.45. Over the past year, DABUR INDIA LTD has achieved a return of -3.93 %. In the last month alone, the return has been -1.95 %. Read More...

DABUR INDIA LTD fundamentals


  • Market cap (Cr)

    86,431.21

  • P/E Ratio (TTM)

    60.18

  • Beta

    0.34

  • Book Value / share

    40.76

  • Return on equity

    22.86%

  • EPS (TTM)

    8.10

  • Dividend yield

    1.13%

  • Net profit/quarter (Cr)

    418.08

info icon alternate text
  • Market cap (Cr)

    86,121.11

  • P/E Ratio (TTM)

    60.18

  • Beta

    0.34

  • Book Value / share

    40.76

  • Return on equity

    22.86%

  • EPS (TTM)

    8.10

  • Dividend yield

    1.13%

  • Net profit/quarter (Cr)

    418.08

info icon alternate text

DABUR INDIA LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 2448.26
Operating Expense 2017.82
Net Profit 418.08
Net Profit Margin (%) 17.07
Earnings Per Share (EPS) 2.36
EBITDA 627.86
Effective Tax Rate (%) 21.96
Particulars SEP 2024 (Values in Cr)
Revenue 2143.58
Operating Expense 1833.12
Net Profit 329.21
Net Profit Margin (%) 15.35
Earnings Per Share (EPS) 1.86
EBITDA 521.67
Effective Tax Rate (%) 23.24
Particulars JUN 2024 (Values in Cr)
Revenue 2514.16
Operating Expense 2096.81
Net Profit 405.39
Net Profit Margin (%) 16.12
Earnings Per Share (EPS) 2.29
EBITDA 606.55
Effective Tax Rate (%) 23.07
Particulars MAR 2024 (Values in Cr)
Revenue 2039.46
Operating Expense 1780.52
Net Profit 283.15
Net Profit Margin (%) 13.88
Earnings Per Share (EPS) 1.60
EBITDA 450.76
Effective Tax Rate (%) 24.11
Particulars DEC 2023 (Values in Cr)
Revenue 2414.36
Operating Expense 1958.93
Net Profit 428.12
Net Profit Margin (%) 17.73
Earnings Per Share (EPS) 2.42
EBITDA 633.37
Effective Tax Rate (%) 23.17
Particulars MAR 2024 (Values in Cr)
Revenue 9135.60
Operating Expense 7586.52
Net Profit 1509.21
Net Profit Margin (%) 16.52
Earnings Per Share (EPS) 8.52
EBITDA 2256.70
Effective Tax Rate (%) 23.26
Particulars MAR 2023 (Values in Cr)
Revenue 8684.35
Operating Expense 7218.20
Net Profit 1373.26
Net Profit Margin (%) 15.81
Earnings Per Share (EPS) 7.75
EBITDA 2063.33
Effective Tax Rate (%) 24.90
Particulars MAR 2022 (Values in Cr)
Revenue 8179.50
Operating Expense 6624.74
Net Profit 1432.93
Net Profit Margin (%) 17.51
Earnings Per Share (EPS) 8.11
EBITDA 2075.37
Effective Tax Rate (%) 24.43
Particulars MAR 2021 (Values in Cr)
Revenue 7184.73
Operating Expense 5778.07
Net Profit 1381.89
Net Profit Margin (%) 19.23
Earnings Per Share (EPS) 7.82
EBITDA 1835.85
Effective Tax Rate (%) 17.90
Particulars MAR 2020 (Values in Cr)
Revenue 6309.80
Operating Expense 5078.23
Net Profit 1170.35
Net Profit Margin (%) 18.54
Earnings Per Share (EPS) 6.62
EBITDA 1557.67
Effective Tax Rate (%) 16.90
Particulars MAR 2024 (Values in Cr)
Book Value / Share 55.68
ROE % 19.23
ROCE % 23.07
Total Debt to Total Equity 0.13
EBITDA Margin 23.24
Particulars MAR 2023 (Values in Cr)
Book Value / Share 50.64
ROE % 19.61
ROCE % 23.32
Total Debt to Total Equity 0.13
EBITDA Margin 22.62
Particulars MAR 2022 (Values in Cr)
Book Value / Share 47.41
ROE % 21.72
ROCE % 26.05
Total Debt to Total Equity 0.10
EBITDA Margin 23.51
Particulars MAR 2021 (Values in Cr)
Book Value / Share 43.36
ROE % 23.76
ROCE % 27.04
Total Debt to Total Equity 0.07
EBITDA Margin 24.34
Particulars MAR 2020 (Values in Cr)
Book Value / Share 37.38
ROE % 23.66
ROCE % 26.15
Total Debt to Total Equity 0.10
EBITDA Margin 22.95
Particulars MAR 2024 (Values in Cr)
Book Value / Share 39.03
ROE % 22.86
ROCE % 27.82
Total Debt to Total Equity 0.11
EBITDA Margin 24.70
Particulars MAR 2023 (Values in Cr)
Book Value / Share 35.48
ROE % 22.60
ROCE % 27.88
Total Debt to Total Equity 0.10
EBITDA Margin 23.76
Particulars MAR 2022 (Values in Cr)
Book Value / Share 33.17
ROE % 25.46
ROCE % 31.62
Total Debt to Total Equity 0.07
EBITDA Margin 25.37
Particulars MAR 2021 (Values in Cr)
Book Value / Share 30.50
ROE % 27.73
ROCE % 32.51
Total Debt to Total Equity 0.03
EBITDA Margin 25.55
Particulars MAR 2020 (Values in Cr)
Book Value / Share 25.89
ROE % 27.40
ROCE % 31.31
Total Debt to Total Equity 0.05
EBITDA Margin 24.69
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 666.36
Total Assets 15122.68
Total Liabilities 15122.68
Total Equity 10303.08
Share Outstanding 1772039162
Price to Book Ratio 13.40
Return on Assets (%) 12.18
Return on Capital (%) 16.08
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 325.92
Total Assets 13654.37
Total Liabilities 13654.37
Total Equity 9441.43
Share Outstanding 1767856483
Price to Book Ratio 15.36
Return on Assets (%) 12.50
Return on Capital (%) 16.35
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 570.14
Total Assets 12284.53
Total Liabilities 12284.53
Total Equity 8421.85
Share Outstanding 1767856483
Price to Book Ratio 16.18
Return on Assets (%) 14.15
Return on Capital (%) 18.72
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1329.03
Total Assets 10847.13
Total Liabilities 10847.13
Total Equity 7700.22
Share Outstanding 1767425349
Price to Book Ratio 17.73
Return on Assets (%) 15.61
Return on Capital (%) 21.03
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 811.37
Total Assets 9354.01
Total Liabilities 9354.01
Total Equity 6642.21
Share Outstanding 1767063892
Price to Book Ratio 17.39
Return on Assets (%) 15.44
Return on Capital (%) 20.32
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 71.11
Total Assets 10532.81
Total Liabilities 10532.81
Total Equity 6915.37
Share Outstanding 1772039162
Price to Book Ratio 13.40
Return on Assets (%) 14.32
Return on Capital (%) 19.82
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 33.40
Total Assets 9352.44
Total Liabilities 9352.44
Total Equity 6286.88
Share Outstanding 1767856483
Price to Book Ratio 15.36
Return on Assets (%) 14.68
Return on Capital (%) 20.06
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 136.18
Total Assets 8592.00
Total Liabilities 8592.00
Total Equity 5863.87
Share Outstanding 1767856483
Price to Book Ratio 16.18
Return on Assets (%) 16.67
Return on Capital (%) 22.48
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 834.74
Total Assets 7504.16
Total Liabilities 7504.16
Total Equity 5391.22
Share Outstanding 1767425349
Price to Book Ratio 17.73
Return on Assets (%) 18.41
Return on Capital (%) 24.93
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 525.60
Total Assets 6100.11
Total Liabilities 6100.11
Total Equity 4574.23
Share Outstanding 1767063892
Price to Book Ratio 17.39
Return on Assets (%) 19.18
Return on Capital (%) 24.96
Particulars MAR 2024 (Values in Cr)
Net Income 2358.74
Cash from Operations 2507.39
Cash from Investing -971.74
Cash from Financing -1161.18
Net change in Cash -119.45
Free Cash Flow 3071.25
Particulars MAR 2023 (Values in Cr)
Net Income 2218.68
Cash from Operations 1982.88
Cash from Investing -586.54
Cash from Financing -1035.24
Net change in Cash -133.35
Free Cash Flow 2491.97
Particulars MAR 2022 (Values in Cr)
Net Income 2268.68
Cash from Operations 2189.93
Cash from Investing -1275.45
Cash from Financing -490.49
Net change in Cash 36.39
Free Cash Flow 2564.06
Particulars MAR 2021 (Values in Cr)
Net Income 2056.02
Cash from Operations 2435.99
Cash from Investing -1405.78
Cash from Financing -613.41
Net change in Cash 95.48
Free Cash Flow 2747.20
Particulars MAR 2020 (Values in Cr)
Net Income 1727.64
Cash from Operations 1922.56
Cash from Investing -516.84
Cash from Financing -1042.97
Net change in Cash 53.81
Free Cash Flow 2340.02
Particulars MAR 2024 (Values in Cr)
Net Income 1966.70
Cash from Operations 2043.66
Cash from Investing -737.50
Cash from Financing -921.82
Net change in Cash -5.99
Free Cash Flow 2500.21
Particulars MAR 2023 (Values in Cr)
Net Income 1828.67
Cash from Operations 1994.26
Cash from Investing -618.57
Cash from Financing -939.83
Net change in Cash 3.51
Free Cash Flow 2404.31
Particulars MAR 2022 (Values in Cr)
Net Income 1896.31
Cash from Operations 1648.40
Cash from Investing -682.80
Cash from Financing -634.79
Net change in Cash 2.36
Free Cash Flow 1945.17
Particulars MAR 2021 (Values in Cr)
Net Income 1683.31
Cash from Operations 1978.77
Cash from Investing -1121.40
Cash from Financing -555.04
Net change in Cash 27.73
Free Cash Flow 2228.67
Particulars MAR 2020 (Values in Cr)
Net Income 1408.47
Cash from Operations 1423.71
Cash from Investing -331.54
Cash from Financing -826.00
Net change in Cash -2.77
Free Cash Flow 1688.25
Company Name Price P/E P/B Market Cap 52 Week Low/High
BRITANNIA INDUSTRIES LTD 5446.05 60.30 40.86 131178.08 4506.50 / 6473.10
NESTLE INDIA LIMITED 2385.45 74.90 57.35 229994.87 2115.00 / 2777.00
FOODS & INNS LIMITED 87.89 26.63 1.25 645.24 75.20 / 164.85
HINDUSTAN UNILEVER LTD. 2341.25 52.78 11.13 550098.05 2136.00 / 3034.50
Company Name Price P/E P/B Market Cap 52 Week Low/High
BRITANNIA INDUSTRIES LTD 5446.05 61.82 47.29 131178.08 4506.50 / 6473.10
COLGATE PALMOLIVE LTD. 2583.10 48.07 42.50 70256.61 2324.00 / 3893.00
NESTLE INDIA LIMITED 2385.45 74.24 55.86 229994.87 2115.00 / 2777.00
FOODS & INNS LIMITED 87.89 25.62 1.25 645.24 75.20 / 164.85

DABUR INDIA LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
487.75 0.84 redarrow
red-green-graph indicator
6 Bearish
10 Bullish
  • 5 Days 485.00
  • 26 Days 485.40
  • 10 Days 483.20
  • 50 Days 493.00
  • 12 Days 482.90
  • 100 Days 508.10
  • 20 Days 483.80
  • 200 Days 528.70
483.97 PIVOT

First Support

480.98

First Resistance

486.63

Second Support

478.32

Second Resistance

489.62

Third Support

475.33

Third Resistance

492.28

RSI

51.46

ADX

15.19

MACD

-2.47

Williams % R

-16.27

Commodity Channel Index (CCI)

47.32

Date

2025-04-30

Week

1087733.00

Same Day

1401981.00

Month

1469032.00

1 Year

0.35

3 Year

0.51

Over 1 Month

-1.95%

down

Over 1 Year

-3.93%

down

Over 3 Months

-8.60%

down

Over 3 Years

-4.34%

down

Over 6 Months

-10.77%

down

Over 5 Years

-0.06%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

DABUR INDIA LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
5.36%
Promoter Holdings
66.27%
FII
12.67%
DII
15.68%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Vic Enterprises Private Limited (owned By Mr. V C Burman) 2.17794E8 (12.29%) Shareholding of Promoter and Promoter Group
Chowdry Associates (owned By Mr. Saket Burman) 2.090838E8 (11.8%) Shareholding of Promoter and Promoter Group
Gyan Enterprises Private Limited (owned By Mr. Amit Burman) 1.9337998E8 (10.91%) Shareholding of Promoter and Promoter Group
Puran Associates Private Limited (owned By Dr. Anand Chand Burman & Mrs. Minnie Burman) 1.89212E8 (10.68%) Shareholding of Promoter and Promoter Group
Ratna Commercial Enterprises Private Limited (owned By Mr. Pradip Burman Family Trust) 1.58955604E8 (8.97%) Shareholding of Promoter and Promoter Group
Milky Investment And Trading Company (owned By Dr. Anand Chand Burman) 1.06147503E8 (5.99%) Shareholding of Promoter and Promoter Group
Life Insurance Corporation Of India 9.6203582E7 (5.43%) Public Shareholding
Burmans Finvest Private Limited (owned By Mrs. Monica Burman) 5.3012986E7 (2.99%) Shareholding of Promoter and Promoter Group
Nps Trust 3.4136892E7 (1.93%) Public Shareholding
M.b. Finmart Private Limited (owned By Mr. Mohit Burman) 2.6506492E7 (1.5%) Shareholding of Promoter and Promoter Group
Icici Prudential Large & Mid Cap Fund 2.6437692E7 (1.49%) Public Shareholding
Sbi Nifty Next 50 Index Fund 2.5939526E7 (1.46%) Public Shareholding
Hdfc Mutual Fund - Hdfc Multi Cap Fund 1.8766551E7 (1.06%) Public Shareholding
Windy Investments Private Limited (owned By Mr. Gaurav Burman) 1.7670995E7 (1.0%) Shareholding of Promoter and Promoter Group
Anand Chand Burman 660000.0 (0.04%) Shareholding of Promoter and Promoter Group
Gauri Tandon 677995.0 (0.04%) Shareholding of Promoter and Promoter Group
Pradip Burman 597630.0 (0.03%) Shareholding of Promoter and Promoter Group
Saket Burman 300000.0 (0.02%) Shareholding of Promoter and Promoter Group
Asha Burman 154000.0 (0.01%) Shareholding of Promoter and Promoter Group
Indira Burman 100000.0 (0.01%) Shareholding of Promoter and Promoter Group
Minnie Burman 30000.0 (0.0%) Shareholding of Promoter and Promoter Group
Monica Burman 15000.0 (0.0%) Shareholding of Promoter and Promoter Group
Mohit Burman 60000.0 (0.0%) Shareholding of Promoter and Promoter Group
Sahiwal Investment And Trading Company 15000.0 (0.0%) Shareholding of Promoter and Promoter Group
Eishana Burman 6000.0 (0.0%) Shareholding of Promoter and Promoter Group
Chetan Burman 30000.0 (0.0%) Shareholding of Promoter and Promoter Group
Shivani Burman 30000.0 (0.0%) Shareholding of Promoter and Promoter Group
Vivek Chand Burman 15000.0 (0.0%) Shareholding of Promoter and Promoter Group
Pradip Burman & Ors (pradip Burman) (huf) 30000.0 (0.0%) Shareholding of Promoter and Promoter Group
Gyan Chand Burman & Others (amit Burman) (huf) 30000.0 (0.0%) Shareholding of Promoter and Promoter Group
Ashok Chand Burman & Bros (anand Chand Burman) (huf) 30000.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

DABUR INDIA LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
10 Nov 2023 2.75 Interim 10 Nov 2023 Equity shares
21 Jul 2023 2.7 Final 24 Jul 2023 Equity shares
03 Nov 2022 2.5 Interim 04 Nov 2022 Equity shares
21 Jul 2022 2.7 Final 25 Jul 2022 Equity shares
11 Nov 2021 2.5 Interim 12 Nov 2021 Equity shares
29 Jul 2021 3.0 Final 02 Aug 2021 Equity shares
11 Nov 2020 1.75 Interim 12 Nov 2020 Equity shares
13 Aug 2020 1.6 Final 17 Aug 2020 Equity shares
13 Nov 2019 1.4 Interim 14 Nov 2019 Equity shares
07 Aug 2019 1.5 Final 09 Aug 2019 Equity shares
09 Nov 2018 1.25 Interim 12 Nov 2018 Equity shares
04 Jul 2018 1.25 Final 06 Jul 2018 Equity shares
04 Jul 2018 5.0 Special 06 Jul 2018 Equity shares
07 Nov 2017 1.25 Interim 08 Nov 2017 Equity shares
05 Jul 2017 1.0 Final 07 Jul 2017 Equity shares
03 Nov 2016 1.25 Interim 04 Nov 2016 Equity shares
29 Jun 2016 1.0 Final 01 Jul 2016 Equity shares
05 Nov 2015 1.25 Interim 06 Nov 2015 Equity shares
29 Jun 2015 0.75 Final 01 Jul 2015 Equity shares
19 Sep 2014 1.25 Interim 22 Sep 2014 Equity shares
27 Jun 2014 1.0 Final 01 Jul 2014 Equity shares
05 Nov 2013 0.75 Interim 06 Nov 2013 Equity shares
21 Jun 2013 0.85 Final 25 Jun 2013 Equity shares
31 Oct 2012 0.65 Interim 01 Nov 2012 Equity shares
27 Jun 2012 0.75 Final 29 Jun 2012 Equity shares
04 Nov 2011 0.55 Interim 08 Nov 2011 Equity shares
29 Jun 2011 0.65 Final 01 Jul 2011 Equity shares
02 Nov 2010 0.5 Interim 03 Nov 2010 Equity shares
03 Aug 2010 1.25 Final 05 Aug 2010 Equity shares
30 Oct 2009 0.75 Interim 03 Nov 2009 Equity shares
29 Jun 2009 1.0 Final 01 Jul 2009 Equity shares
02 Feb 2009 0.75 Interim 03 Feb 2009 Equity shares
19 Jun 2008 0.75 Final 23 Jun 2008 Equity shares
29 Oct 2007 0.75 Interim 30 Oct 2007 Equity shares
16 Mar 2007 0.75 Interim 20 Mar 2007 Equity shares
03 Nov 2006 1.0 Interim 01 Jan 0001 Equity shares
28 Oct 2005 0.0 Interim 31 Oct 2005 Equity shares
29 Jun 2005 0.0 Final 01 Jul 2005 Equity shares
Ex-Date Ex-Bonus Ratio
10 Sep 2010 08 Sep 2010 1:1
29 Jan 2007 25 Jan 2007 1:2
20 Jan 2006 19 Jan 2006 1:1
Ex-Date Old FV NEW FV Record Date
29 Nov 2000 10.0 1.0 15 Dec 2000
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
10 Nov 2023 2.75 Interim 10 Nov 2023 Equity shares
21 Jul 2023 2.7 Final 24 Jul 2023 Equity shares
03 Nov 2022 2.5 Interim 04 Nov 2022 Equity shares
21 Jul 2022 2.7 Final 25 Jul 2022 Equity shares
11 Nov 2021 2.5 Interim 12 Nov 2021 Equity shares
29 Jul 2021 3.0 Final 02 Aug 2021 Equity shares
11 Nov 2020 1.75 Interim 12 Nov 2020 Equity shares
13 Aug 2020 1.6 Final 17 Aug 2020 Equity shares
13 Nov 2019 1.4 Interim 14 Nov 2019 Equity shares
07 Aug 2019 1.5 Final 09 Aug 2019 Equity shares
09 Nov 2018 1.25 Interim 12 Nov 2018 Equity shares
04 Jul 2018 1.25 Final 06 Jul 2018 Equity shares
04 Jul 2018 5.0 Special 06 Jul 2018 Equity shares
07 Nov 2017 1.25 Interim 08 Nov 2017 Equity shares
05 Jul 2017 1.0 Final 07 Jul 2017 Equity shares
03 Nov 2016 1.25 Interim 04 Nov 2016 Equity shares
29 Jun 2016 1.0 Final 01 Jul 2016 Equity shares
05 Nov 2015 1.25 Interim 06 Nov 2015 Equity shares
29 Jun 2015 0.75 Final 01 Jul 2015 Equity shares
19 Sep 2014 1.25 Interim 22 Sep 2014 Equity shares
27 Jun 2014 1.0 Final 01 Jul 2014 Equity shares
05 Nov 2013 0.75 Interim 06 Nov 2013 Equity shares
21 Jun 2013 0.85 Final 25 Jun 2013 Equity shares
31 Oct 2012 0.65 Interim 01 Nov 2012 Equity shares
27 Jun 2012 0.75 Final 29 Jun 2012 Equity shares
04 Nov 2011 0.55 Interim 08 Nov 2011 Equity shares
29 Jun 2011 0.65 Final 01 Jul 2011 Equity shares
02 Nov 2010 0.5 Interim 03 Nov 2010 Equity shares
03 Aug 2010 1.25 Final 05 Aug 2010 Equity shares
30 Oct 2009 0.75 Interim 03 Nov 2009 Equity shares
29 Jun 2009 1.0 Final 01 Jul 2009 Equity shares
02 Feb 2009 0.75 Interim 03 Feb 2009 Equity shares
19 Jun 2008 0.75 Final 23 Jun 2008 Equity shares
29 Oct 2007 0.75 Interim 30 Oct 2007 Equity shares
16 Mar 2007 0.75 Interim 20 Mar 2007 Equity shares
03 Nov 2006 1.0 Interim 01 Jan 0001 Equity shares
28 Oct 2005 0.0 Interim 31 Oct 2005 Equity shares
29 Jun 2005 0.0 Final 01 Jul 2005 Equity shares
Ex-Date Ex-Bonus Ratio
10 Sep 2010 08 Sep 2010 1:1
29 Jan 2007 25 Jan 2007 1:2
20 Jan 2006 19 Jan 2006 1:1
Ex-Date Old FV NEW FV Record Date
29 Nov 2000 10.0 1.0 15 Dec 2000

Dabur India Share Result Highlights   

Dabur India Ltd is a leading Indian consumer goods company that works across various sectors like health, hair, skin and home care as well as in the food and beverages sector. As of 17 January, 2025, 04:01 pm, the Dabur India Share price stood at ₹526.05 per share.

Dabur India Share Annual Reports 

Dabur India’s operating income, according to its Annual Report 2023-24, grew by 7.6% YoY while its operating profit grew by 11.0% YoY. Its net profit during the same duration grew by 6.5% YoY while its net profit margins declined from 14.8% in FY23 to 14.6% in FY24.

Dabur India Share Dividend

Dabur India announced its last dividend in the quarter ending September 2024. It declared a dividend of ₹2.75 which translates to a yield of 1.57%.

Popular FAQs

  1. Who is the CEO of Dabur India Ltd?

    The CEO of Dabur India Ltd is Mohit Malhotra.

  2. When was Dabur India Ltd established?

    Dabur India Ltd was established in 1884.

  3. What factors influence the Dabur India Share Price?

    Factors such as the company’s revenue growth, profit margins, and debt-to-equity ratio affect the Dabur India Share Price.

  4. Is Dabur India Ltd debt-free?

    No, the company is not debt-free.

  5. What is the CAGR of Dabur India Share?

    The company’s CAGR over the last 10 years stood at 8%.

  6. How has the Dabur India Share Price performed over the past year?

    Dabur India’s operating income, according to its Annual Report 2023-24, grew by 7.6% YoY, while its operating profit grew by 11.0% YoY. Its net profit increased by 6.5% YoY, whereas net profit margins declined from 14.8% in FY23 to 14.6% in FY24.

DABUR INDIA LTD Share Price

Dabur India Limited is one of the leading FMCG Companies in India and a global leader in Ayurveda with a portfolio of over 250 Herbal and Ayurvedic products. The Company operate in key consumer products categories like Hair Care, Oral Care, Health Care, Skin Care, Home Care and Foods. Their FMCG portfolio includes five flagship brands with distinct brand identities, 'Dabur' as the master brand for natural healthcare products, Vatika for premium personal care, Hajmola for digestives, Real for fruit juices and beverages and Fem for fairness bleaches and skin care products.

The Company operates through three Strategic Business Units, Consumer Care Division (CCD), International Business Division (IBD) and Consumer Health Division (CHD). Their CCD business is divided into four key portfolios: healthcare, personal care, home care and foods. Their CHD business offers a range of healthcare products. Their IBD business includes brands, such as Dabur Amla and Vatika.

The Company has a strong manufacturing footprint with own plants at 14 locations in India, which includes Badshah Masala manufacturing unit in Umbergaon, Gujarat. The Foods business is serviced by manufacturing facilities at Newai (Rajasthan) and Siliguri (West Bengal). Outside India, the company has manufacturing facilities in Dubai, Sharjah, Ras-al- Khaimah, Egypt, Nigeria, Nepal and Bangladesh.

The company has a wide distribution network, covering 6 million retail outlets with a high penetration in both urban and rural markets. Their products also have a huge presence in the overseas markets and are available in over 120 countries across the globe. Dabur today has manufacturing presence across 8 countries.

Dabur India Limited was incorporated on September 16, 1975 for manufacture of high-grade edible & industrial guargum powder and its sophisticated derivatives. In the year 1978, the company launched Hajmola tablet, an Ayurvedic medicine used as a digestive aid. In the year 1979, they set Dabur Research Foundation. Also, they commenced commercial production at the most modern herbal medicines plant in Sahibabad. In the year 1986, the Company was converted into a Public Limited Company. In the year 1988, they launched the pharmaceutical medicines.

In the year 1989, the company converted the Ayurvedic digestive formulation into a children's fun product with the launch of Hajmola Candy. In the year 1992, they launched a new range of coconut oil under the brand name 'Anmol'. Also, they developed Dab 10, an intermediate for anti-cancer drug, 'Taxol'. The Company entered into a Joint Venture Agreement with Guldenhorst BV Netherland to form a Company for manufacture and marketing of all types of bubble gum, chewing gum, toffees, chocolate, cocoa related products and sugar based spreading creams etc.

In the year 1994, the company entered into capital market with their public issue. Also, they entered into oncology segment during the year. In the year 1996, the company entered into foods business with the launch of Real Fruit Juice, the first local brand of 100% pure natural fruit juices made to international standards. In 1997, the company set up a new manufacturing unit with a high degree of automation at Baddi (H.P.) to produce company's well-known brands, namely Chyawanprash, Janma Ghunti, Ayurvedic Oils and Asva-Arishtas.

In the year 1998, Burman family handed over management of the company to professionals. The company signed a joint venture with Bongrain International SA of France to form a new company under the name of Dabon International Ltd. In the year 1999, the company entered into an agreement with their Spanish partner Agrolimen to offload their 49% stake in the joint venture company General De Confiteria India Ltd in favor of an Agrolimen Group Company.

In the year 2000, the company launched Efarelle Comfort, a natural menstrual pain reliever. Also, the company's ayurvedic specialties division launched plain isabgol husk under the brand name Nature Care. In the year 2001, the company entered into the highly specialized area of cancer therapy.

In the year 2003, the company demerged their pharmaceuticals business from the FMCG business into a separate company as part of plans to provider greater focus to both the businesses. With this, the company now largely comprises of the FMCG business that include personal care products, healthcare products and Ayurvedic Specialities, while the Pharmaceuticals business would include Allopathic, Oncology formulations and Bulk Drugs. Dabur Oncology Plc, a subsidiary of Dabur India, would also be part of the Pharmaceutical business. Also, they made a tie up with Free Markets Inc for using leading edge technologies to execute online markets for its procurement needs.

In the year 2005, the company acquired Balsara's Hygiene and Home products businesses, a leading provider of Oral Care and Household Care products in the Indian market for the consideration of Rs 143-crore all-cash deal. In the year 2006, Besta Cosmetics Ltd was amalgamated with the company with effect from April 1, 2006. Also, the company incorporated a subsidiary company under the name Asian Consumer Care Pakistan Pvt Ltd to sell FMCG products in Pakistan. In the year 2007, Dabur Foods Ltd was amalgamated with the company with effect from April 1, 2007 to extract synergies and unlock operational efficiencies.

During the year 2009-10, the company acquired 20% of the equity share capital of Fem Care Pharma Limited (FEM) from the public shareholders, in addition to the controlling stake of 72.15% acquired from their existing promoters thereby increasing the total controlling stake to 92.15%. Also, as per the scheme of amalgamation, Fem Care Pharma Ltd was amalgamated with the company with effect from April 1, 2009. The scheme became effective on June 18, 2010.

During the year 2010-11, the company acquired Turkey's leading personal care products maker Hobi Kosmetik Group through Dabur International Ltd, a wholly owned subsidiary of the company for USD 69 million. In January 2011, they acquired 100% equity in Namaste Laboratories LLC of the US, a leading ethnic hair care group based in Chicago with operations in US, Europe and Africa, through Dermoviva Skin Essentials Inc, a wholly owned subsidiary of the Company for USD 100 million. They launched India's first fruit-flavoured Chyawanprash. Dabur Chyawanprash was launched in Orange and Mango flavoured variants.

In the year 2011, the company launched their first-ever online shopping portal www.daburuveda.com. With this, the company is the first Indian FMCG company to launch a dedicated online shopping portal for its beauty products range. The portal will be the online gateway for consumers to know, understand, buy and gift the exclusive Dabur Uveda range of skincare products. The company acquired Ajanta Pharma's over-the-counter energizer brand '30-Plus'.

In January 31, 2012, the company's step down subsidiary, Zeki Plastik Imalati Sanayi ve Ticaret Anonim Sirketi merged with another step down subsidiary - Hobi Kozmetik Imalat Sanayi Ve Ticaret Anonim Sirketi. Accordingly, Zeki Plastik Imalati Sanayi ve Ticaret Anonim Sirketi ceased to be the company's step down subsidiary company with effect from January 31, 2012.

In 2012, Namaste Cosmeticos Ltd, became new step down subsidiary Company in Brazil. The company also expanded its range of fruit juices viz. Real Activ.

In 2013, Dabur Enters Yoghurt Drink Market With Brand Real Activ. The company Expands Skin Care Portfolio and launches Oxy Life Gel Bleach. The company Launches New Fruit Juice Range: Real SupaFruits. Dabur Launches Indias First Oral Health Portal.

In 2014, Dabur Launches India's First Ayurvedic Medical Journal. The company also enters Packaged Coconut Water market with Real Activ.

In 2015 Dabur India Ltd inked an agreement with Starcom MediaVest Group (SMG). The company has introduced an array of professional salon facial products for men and women under the Oxlife brand. The company also introduced the sugar-free version of its popular ayurvedic product Chyawanprash named Ratnaprash SugarFree.

On 12 October 2015, Dabur India announced its entry into the Jasmine Hair Oil category with the launch of Vatika Jasmine Non-Sticky Coconut Hair Oil. The product, developed after extensive research, provides nourishment of coconut oil, jasmine extracts and is enriched with Silicon Oils that helps restore moisture balance in hair and give smooth, manageable less frizzy hair.

On 24 February 2016, Dabur India announced that it has inked a license agreement with the Government of India to commercially produce two new Ayurvedic drugs viz. Ayush-64 for treatment of Malaria and Ayush-82 for management of Diabetes. Dabur India also signed a Memorandum of Understanding (MoU) with the Central Council of Research in Ayurvedic Sciences (CCRAS), an apex research body under the Ministry of AYUSH, Government of India, for collaboration and co-operation in pharmaceutical R&D for different novel dosage forms and drug development in Ayurveda. Dabur India Ltd said it is preparing to commercially produce the two new Ayurvedic medicines within the next 6 months and these medicines will be available in various formats. The Ayurvedic formulations for both these medicines were developed by CCRAS.

On 1 November 2016, Dabur South Africa (Pty) Ltd announced an agreement with South Africa's CTL Group of Companies to acquire its Personal Care, Hair Care & Creams businesses for 18.8 million ZAR (around USD 1.5 million). Under the agreement, Dabur South Africa (Pty) Ltd - the wholly-owned subsidiary of Dabur International Ltd - will acquire the business of development, manufacturing, packaging and sale of Personal Care products (Hair Care and Creams) of CTL Contracting Proprietary Limited, in addition to certain equipment of Carbotec Laboratories Proprietary Limited and immovable property from CTL Management and Personnel Services Proprietary Limited. Dabur International Ltd is an overseas subsidiary of Dabur India.

On 7 February 2017, Dabur India's pure-play beauty retail venture NewU announced the launch of Sri Lanka's Ayurvedic beauty brand Spice Island in India. This marks the Indian entry of Spice Island, which will be available exclusively at NewU outlets across the country, and will feature a range of premium Skin Care, Bath & Body Care and Hair Care products.

On 14 March 2017, Dabur India announced the launch of first-ever Mobile Honey-Testing Lab in India. This unique on-the-go lab has been designed specially to check raw Honey at source to reduce adulteration in honey and ensure that purity is maintained.

On 29 March 2017, Dabur India announced the commissioning of its new manufacturing facility in Tezpur, Assam. The plant, set up with an investment of Rs 250 crore, is the most modern and environment friendly manufacturing facility in the consumer goods industry in India. The manufacturing facility, located in Balipara Industrial area, will manufacture the entire range of Dabur's Ayurvedic Medicines, Health Supplements, Hair Oils, Shampoos, Toothpastes, Skin Care and Home Care products. The new facility has been constructed in a record time of eight months since its ground-breaking in July 2016 and will house the most modern production lines for consumer products in India. The state-of-the-art manufacturing facility is spread over 30 acres of land and is expected to give a quantum leap to the capacity of Dabur India to meet the growing demand for its products.

On 26 September 2017, Dabur India announced its alliance with Amazon to take its products global. Dabur's collaboration with Amazon will help it expand and increase its product penetration into the US market. Under this collaboration, Amazon will help Dabur take around 30 products from its popular range such as, Vatika hair oil, Meswak toothpaste, Red toothpaste, Chyawanprash to name a few, to consumers in the US. Along with the existing wide range, Dabur will also offer an exclusive range of products specially created for Amazon's global customers. As part of this association, Amazon through its Global Selling Program will provide an avenue to Dabur to take its vast range of well-known and sough-after ayurvedic and natural products to millions of global customers on Amazon.com in the US and eventually across other Amazon marketplaces.

In year 2018-19, Dabur Herbal Toothpaste was relaunched with a refurbished marketing mix and packaging upgrade with enhanced
focus on ingredients. During fiscal 2019-20, the Company launched new products in India, mainly including Ethnic Masala Range of Juices in 2 additional variants, Masala Mixed Fruit and Masala Aam Panna, Real Mixed Berries Juice, Real Aloe Vera Kiwi Juice, Real Fruit ORS, Real Koolerz - INR 10 SKU of mango drink, Babool Ayurvedic Toothpaste, Dabur Glucoplus C - Mango Flavour, Amla Kids Hair Oil and Shampoo, Fem Fruit Crème Bleach, a range of 7 Ayurvedic Single Herb Churnas which includes three Immunity-boosters like GiloyChurna, Amla Churna and Ashwagandha Churna. The other products in this range are Hareetaki (Harad) Churna, Neem Churna, Arjun ChhalChurna and Brahmi Churna, Fem Fruit Crème Bleach, Nature Care Kabz Over for treatment of constipation, a new variant of Hajmola called the HajmolaChatpati Hing, two new fragrances in Odonil Aerosol, Floral Bliss and Ocean Breeze, Dabur ArshoghaniVati, an Ayurvedic medicine beneficial for treatment of piles, Dabur Tulsi drops, Dabur Immunity Kit, Dabur Amla Juice, Dabur Giloy-Neem-Tulsi Juice, Dabur Hand Sanitize, Dabur &Dazzl Surface Sanitizers and Odonil Air Sanitizer. In Overseas markets, it launched VatikaMenz Hair Tonic, Dabur Amla Keratin Serum, Dabur Herbolene Natural Jelly, Real Juices in UAE, Japan and Bahrain, Vatika Hair Wax, ORS Olive Oil Fix-It Range, Vatika Hair Food and Dabur Honitus Herbal Lozenges in UAE. In terms of distribution, the Company increased its direct reach from 1.1 million to 1.2 million, taking the total reach to 6.7 million outlets. Excel Investments (FZC) (previously FZE), in Sharjah, UAE, had become a step down subsidiary company of Dabur India Limited w.e.f. 20th August, 2019 upon acquisition of management control of this new subsidiary by Dabur International Limited (a wholly owned subsidiary of Dabur India Limited).

During the year 2020-21, Company expanded their portfolio with the launch of new brands like Dabur Vedic Suraksha Tea, Dabur Pure Herbs tablets and Dabur Himalayan Apple Cider Vinegar. It launched the Dabur Vedic Suraksha Tea. The growth in this portfolio was led by immunity-building medicines like Giloy Ghanvati tablets, Stresscom (Ashwagandha) capsules and premium Chyawanprash variant Ratnaprash. A host of new products were also launched during the year, like Dabur Nasal Drops, to expand the Dabur Ayurvedic Ethicals portfolio. Apart from these, the Company entered the Siddha medicines market with the launch of Kabasura Kudineer, which possesses strong anti-inflammatory, analgesic, anti-viral, anti-bacterial, anti-fungal, antioxidant, hepato-protective, anti-pyretic, anti-asthmatic and immunomodulatory properties. Herbodynamic India Limited was incorporated on 24 February, 2021 as a wholly owned subsidiary Company of the Company. The Company expanded the Honey portfolio with the launch of Tulsi Honey and Ashwagandha Honey.

During the year 2022, the Company focused on their power brands, comprising of Dabur Chyawanprash, Dabur Honey, Dabur Lal Tail, Dabur Honitus, Pudin Hara, Dabur Red Paste, Dabur Amla Hair Oil, Real and Vatika. In terms of distribution network, they increased direct reach from 1.28 million to 1.31 million, taking the total reach to 6.9 million outlets. It also added another exclusive brand London Notes' for fragrances category and launched body mists. It launched various new products such as Dabur Vatika Shampoo, PET Fruit Juice etc.

During the year 2022-23, Herbodynamic India Limited, which was a wholly owned subsidiary of the Company has ceased to be subsidiary of the Company w.e.f. January 11, 2023. Asian Consumer Care Private Limited (Bangladesh), step down subsidiary of the Company had become a step down wholly owned subsidiary of the Company w.e.f. November 24, 2022, upon acquisition of remaining 24% of equity shares held by the Joint Venture partner- M/s Advanced Chemicals Industries Limited. Further, post-acquisition, name of Asian Consumer Care Private Limited was changed to Dabur Bangladesh Private Limited w.e.f. February 16, 2023. The Company had acquired 51% equity shareholding of Badshah Masala Private Limited from its existing shareholders and promoters and consequently upon the acquisition, Badshah has become a subsidiary of the Company w.e.f. January 2, 2023.

The Company launched Dabur Cool King Hair Oil during the year 2022-23. New product like Vatika Ayurvedic Shampoo, Dabur Herb'l Toothpaste Range, Hajmola LimCola and ChatCola variants, Badam Amla Hair Oil, and Dabur Baby were also introduced in the market taking the count to 25. Herbal Plus (with ingredients like Ginger, coconut, and baking soda) and Herb'l Kids, got launched during 2023.

In 2023-24, Company acquired 51% equity stake in Badshah Masala Pvt Ltd and made it a subsidiary on 2 January, 2023. It launched 14 new products in 2024. These launches also marked Dabur's entry into several emerging and growing categories like mosquito repellent liquid vapourisers, cooling hair oils, gel toothpastes, teas, and shower gels.

Parent organization Dabur Group
NSE symbol DABUR
Founded 1975
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Dabur India Ltd?

Answer Field

The share price of Dabur India Ltd for NSE is ₹ 487.75 and for BSE is ₹ 486.

What is the Market Cap of Dabur India Ltd?

Answer Field

The market cap of Dabur India Ltd for NSE is ₹ 8,64,31.21 Cr. and for BSE is ₹ 8,61,21.11 Cr. as of now.

What is the 52 Week High and Low of Dabur India Ltd?

Answer Field

The 52 Week High and Low of Dabur India Ltd for NSE is ₹ 672.00 and ₹ 433.30 and for BSE is ₹ 672.00 and ₹ 420.05.

How to Buy Dabur India Ltd share?

Answer Field

You can trade in Dabur India Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Dabur India Ltd?

Answer Field

The 1 year returns on the stock has been -3.93%.

What is the Current Share Price of Dabur India Ltd?

Answer Field

Dabur India Ltd share price is for NSE ₹ 487.75 & for BSE ₹ 486 as on Apr 30 2025 03:30 PM.

What is the Market Cap of Dabur India Ltd Share?

Answer Field

The market cap of Dabur India Ltd for NSE ₹ 8,64,31.21 & for BSE ₹ 8,61,21.11 as on Apr 30 2025 03:30 PM.

What is the P/E Ratio of Dabur India Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Dabur India Ltd share is 60.18.

What is the PB ratio of Dabur India Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Dabur India Ltd share is 40.76.

How to Buy Dabur India Ltd Share?

Answer Field

You can trade in Dabur India Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Dabur India Ltd Share on Bajaj Broking App?

Answer Field

To buy Dabur India Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Dabur India Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|